Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · IEX Real-Time Price · USD
3.040
-0.330 (-9.79%)
At close: Apr 24, 2024, 4:00 PM
3.010
-0.030 (-0.99%)
Pre-market: Apr 25, 2024, 8:46 AM EDT
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $514.04 million as of April 25, 2024. Its market cap has decreased by -25.89% in one year.
Market Cap
514.04M
Enterprise Value
55.05M
1-Year Change
-25.89%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.84B to $514.04M, a decrease of -81.91%. That is a compound annual growth rate of -26.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2024 | 514.00M | -9.79% |
| Apr 23, 2024 | 569.80M | -0.89% |
| Apr 22, 2024 | 574.90M | -2.01% |
| Apr 19, 2024 | 586.70M | 0.27% |
| Apr 18, 2024 | 585.10M | -1.42% |
| Apr 17, 2024 | 593.50M | 0.29% |
| Apr 16, 2024 | 591.80M | -1.42% |
| Apr 15, 2024 | 600.30M | -6.57% |
| Apr 12, 2024 | 642.50M | -4.77% |
| Apr 11, 2024 | 674.70M | -1.96% |
| Apr 10, 2024 | 688.20M | -0.98% |
| Apr 9, 2024 | 695.00M | 3.27% |
| Apr 8, 2024 | 673.00M | 0.51% |
| Apr 5, 2024 | 669.60M | -2.22% |
| Apr 4, 2024 | 684.80M | -0.98% |
| Apr 3, 2024 | 691.60M | 0.49% |
| Apr 2, 2024 | 688.20M | -7.08% |
| Apr 1, 2024 | 740.60M | -2.01% |
| Mar 28, 2024 | 755.80M | 0.21% |
| Mar 27, 2024 | 754.20M | 5.94% |
| Mar 26, 2024 | 711.90M | -1.86% |
| Mar 25, 2024 | 725.40M | 0.71% |
| Mar 22, 2024 | 720.30M | -2.74% |
| Mar 21, 2024 | 740.60M | -1.13% |
| Mar 20, 2024 | 749.10M | 0.92% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 583.42M |
| CureVac | 582.10M |
| Mesoblast | 582.07M |
| ProKidney | 581.70M |
| Prime Medicine | 575.71M |
| Mineralys Therapeutics | 567.28M |
| Olema Pharmaceuticals | 559.15M |
| Phibro Animal Health | 551.25M |